Prime

Cancer, diabetes drugs lowered to Sh100 monthly from December

Health secretary James Macharia (left) exchanges documents with Novartis chairman Joerg Reinhardt after signing an MoU on low-cost drugs at the Kenyatta National Hospital, Nairobi on October 15, 2015. PHOTO | GERALD ADERSON

Patients suffering from breast cancer, diabetes and heart diseases will buy drugs at Sh103 ($1) a month in a programme launched by pharmaceutical giant Novartis.

The low-cost drugs will be available from mid-December in government and private hospitals, easing the burden on households.

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.

Get it First!

Stay up to date on the editors' picks of the week.

Latest

  1. PRIME Public participation: Beyond the tick-box

  2. AI is reshaping our architecture, but culture must remain at the centre

  3. PRIME When grandma’s cooking meets Nairobi’s fine dining

  4. What Kenya boards must learn from London Saxon Woods ruling

In the headlines

View All